...
首页> 外文期刊>Cell cycle >Hypoxia enhances the replication of oncolytic herpes simplex virus in p53- breast cancer cells.
【24h】

Hypoxia enhances the replication of oncolytic herpes simplex virus in p53- breast cancer cells.

机译:缺氧增强了溶瘤性单纯疱疹病毒在p53-乳腺癌细胞中的复制。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypoxic cancer cells are refractory to conventional chemotherapy. Herpes simplex virus type-1 (HSV-1)-derived oncolytic viruses are safe for therapy since they lack the neurovirulence gene ICP34.5. Cancer cells containing high MEK activity are permissive to the HSV-1-derived oncolytic virus, R3616. Considering that hypoxia increases MEK activity, we determined whether hypoxic MDA-MB-231 and MCF-7 cells were more permissive to R3616, compared to normoxic cells. We observed nine-fold higher (3.5 x 10e6 pfu/4 x 10e5 pfu/ml) titers in MDA-MB-231 hypoxic cells compared to normoxic; however, hypoxic MCF-7 cells did not yield higher R3616 titers. Markers for early and late viral infection were consistent with this result: (1) virus-induced chaperone-enriched (VICE) domains were observed in MDA-MB-231 cells, and (2) the HSV-1 glycoprotein C (gC), a protein produced late in infection, accumulated in hypoxic MDA-MB-231 cells. Thus, oncolytic R3616 virus may target hypoxic p53(-) breast cancer cells.
机译:缺氧癌细胞对常规化疗是难治的。单纯疱疹病毒1型(HSV-1)衍生的溶瘤病毒由于缺乏神经毒力基因ICP34.5,因此可以安全治疗。含有高MEK活性的癌细胞被HSV-1衍生的溶瘤病毒R3616允许。考虑到缺氧会增加MEK活性,我们确定了缺氧MDA-MB-231和MCF-7细胞是否比常氧细胞更适合R3616。我们观察到MDA-MB-231低氧细胞的滴度比常氧高9倍(3.5 x 10e6 pfu / 4 x 10e5 pfu / ml)。然而,低氧MCF-7细胞不能产生更高的R3616效价。早期和晚期病毒感染的标记与该结果一致:(1)在MDA-MB-231细胞中观察到病毒诱导的伴侣富集(VICE)域,(2)HSV-1糖蛋白C(gC)感染后期产生的一种蛋白质,积累在低氧的MDA-MB-231细胞中。因此,溶瘤性R3616病毒可能靶向缺氧的p53(-)乳腺癌细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号